News
Amgen Is Working On a Wegovy Competitor -- What It Means for Investors
It's a race to the riches in the anti-obesity drug market. This therapeutic area is projected to grow exponentially in the coming years. Novo Nordisk is one of the clear market leaders -- for now --
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
Many healthcare investors look at Johnson & Johnson (NYSE: JNJ) and see a good, safe dividend stock. But I see an investment that's full of uncertainty and risk.
The company continually runs into
Earn $1000 Every Month From These 3 Stocks
When it comes to dividend investing, I am constantly looking for high-quality companies with strong free cash flows that pay safe, reliable, and growing dividends. In today's video, I will show you
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
The healthcare industry is a fantastic place to find passive income. Healthcare is recession-proof, and there's always a need for better technology and new treatments. The industry's top dogs have
2 Beaten-Down Stocks to Buy and Hold for 10 Years
It's easy to find stocks that are lagging broader equities, even in a bull market like the one we're currently in. It's harder to find beaten-down stocks that still look worth buying and holding
3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
Dividend stocks can be great assets for you in retirement. They can provide you with some recurring income, and they can be relatively safe places to invest your money into for a while. Not all
2 No-Brainer Dividend Stocks to Buy in May
Dividends may be boring but are essential to building a well-balanced portfolio. After all, dividend payments have accounted for approximately 85% of the S&P 500's total returns since 1960, per a
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
After steadily raising its payout by 163% over the past 15 years, Pfizer (NYSE: PFE) continues to be one of the most reliable pharma stocks an income-seeking investor can reach for these days. The
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Healthcare doesn't get the hype that other industries -- say, technology -- get. However, there arguably isn't an industry more important to humankind's well-being. That's especially true in the
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 8% from a peak they reached this January. The price action doesn't jive with the biopharmaceutical company's cash flows and the
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
Vertex Pharmaceuticals (NASDAQ: VRTX)Q1 2024 Earnings CallMay 06, 2024, 4:30 p.m. ET
Operator
Source Fool.com
2 Magnificent Dividend Stocks to Hold for the Next Decade
There are many reasons to invest in excellent dividend stocks. Such investments are often worth the trouble regardless of whether you're investing for the dividend, or for making capital gains from
3 Reasons to Buy AbbVie Stock on the Dip
It's been more than a year since AbbVie (NYSE: ABBV) lost patent exclusivity for its most important product, Humira, an immunology medicine. Though this was a long time coming, the market reacted as
3 No-Brainer Stocks to Buy in May
Don't believe the adage to "sell in May and go away." Buying stocks can still be a smart move, especially if you're a long-term investor.
Three Motley Fool contributors have identified stocks they
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Weight loss translates to investor profits. Just look at Eli Lilly and Novo Nordisk. Both stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more than
Why Amgen Stock Zoomed Nearly 12% Higher Today
Amgen (NASDAQ: AMGN) released its latest set of quarterly results after market hours Thursday, and investors rewarded the pharmaceutical company the following day with a lift to its share price. The
Zoetis (ZTS) Q1 2024 Earnings Call Transcript
Why Zoetis Stock Popped by Almost 6% on Thursday
Investors were meowing for animal healthcare specialist Zoetis (NYSE: ZTS) on Thursday, following the company's release of its latest quarterly results. These obviously pleased market participants
Cigna Group (CI) Q1 2024 Earnings Call Transcript
QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point of care settings, clinical labs and
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
The phrase "the golden age of biotech" was somewhat popular a few years ago but now seems largely forgotten. Regardless, biotech companies can be excellent long-term investment options for several
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Pfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its stock in serious bargain territory. Speaking
Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript
Sarepta Therapeutics (NASDAQ: SRPT)Q1 2024 Earnings CallMay 01, 2024, 4:30 p.m. ET
Operator
Source Fool.com